Visual and Anatomical Outcomes of a Single Intravitreal Dexamethasone in Diabetic Macular Edema: An 8 Year Real-World Study

Importance: Diabetic macular edema (DME) is a major cause of vision loss in patients with diabetes mellitus. Intravitreal dexamethasone is a treatment option for patients unsuitable for or non-responsive to anti-angiogenic agents. Objective: To quantify visual and anatomical outcomes from an initial...

Descripción completa

Detalles Bibliográficos
Autores principales: Faes, Livia, Mishra, Amit V., Lipkova, Veronika, Balaskas, Konstantinos, Quek, Chrystie, Hamilton, Robin, Held, Ulrike, Sim, Dawn, Sivaprasad, Sobha, Fu, Dun Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299241/
https://www.ncbi.nlm.nih.gov/pubmed/37373573
http://dx.doi.org/10.3390/jcm12123878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299241/
https://www.ncbi.nlm.nih.gov/pubmed/37373573
http://dx.doi.org/10.3390/jcm12123878

Ejemplares similares